DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY WITH SPIKE-AND-WAVE ACTIVATION IN SLEEP

This adverse event was reported 2 times

DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY WITH SPIKE-AND-WAVE ACTIVATION IN SLEEP is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 STIRIPENTOL 1 0.0004
1 PERAMPANEL 1 0.0001
2 CLOBAZAM 1 0.0001
3 TAPENTADOL HYDROCHLORIDE 1 0.0000
4 TOPIRAMATE 1 0.0000
5 DOCUSATE SODIUM 1 0.0000
6 LEVETIRACETAM ORAL 1 0.0000
7 LEVETIRACETAM INJECTION 1 0.0000
8 FENTANYL 1 0.0000
9 LEVETIRACETAM 1 0.0000
See all drugs enriched for association with DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY WITH SPIKE-AND-WAVE ACTIVATION IN SLEEP

These drug classes are most commonly taken by patients reporting DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY WITH SPIKE-AND-WAVE ACTIVATION IN SLEEP:

# Drug class Count
0 Benzodiazepine [EPC] 1
1 Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] 1
2 Nonsteroidal Anti-inflammatory Drug [EPC] 1
3 Opioid Agonist [EPC] 1
See all common drug classes associated with DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY WITH SPIKE-AND-WAVE ACTIVATION IN SLEEP

DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY WITH SPIKE-AND-WAVE ACTIVATION IN SLEEP is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] 1 0.0001
1 Opioid Agonist [EPC] 1 0.0000
2 Benzodiazepine [EPC] 1 0.0000
3 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000
See all drug classes enriched for association with DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY WITH SPIKE-AND-WAVE ACTIVATION IN SLEEP